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Abstract 
Improvements of the substantivity of antibacterial agents in periodontal pockets during active 
therapy is still a challenge. With this study, the improved release kinetics of PVP-iodine by 
simply creating mixtures of a PVP-iodine solution and powder incorporated in different 
concentrations into a commercially available wound paste was investigated.  
Iodine concentrations released by different formulations were determined by a titration 
method and the antibacterial effect was investigated using an agar diffusion method assessing 
the inhibition zone of two representative periopathogenic bacteria (Aggregatibacter 
actinomycetemcomitans and Porphyromonas gingivalis).  
A prolonged release kinetic with up to one third of iodine released after one hour and even an 
ongoing release up to 4 hours was shown. The cumulative concentrations in the immersion 
solutions were sufficiently high to effectively inhibit bacterial growth in the agar test. The pH 
of the different mixtures was adequately buffered when tested in SBF as immersion medium, 
but resulted in acidic conditions when water was used.  
Simple mixing of PVP-powder to an available wound paste may offer an easy method to 
prepare antibacterial products in-office with a potential pocket disinfection duration during 
the scaling and root planning appointment. Nevertheless, its therapeutic usefulness under 
clinical conditions needs further investigation and potential side-effects require clarification.  
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1 Introduction 
The treatment of periodontitis focuses on the effective reduction of bacterial contamination on 
tooth surfaces and adjacent tissues [1]. The removal of hard and soft deposits, i.e. calculus, 
plaque or biofilm, is conventionally achieved by mechanical means. However, any adjunctive 
dissolving or antibacterial action would be desirable as the pursued complete instrumentation 
– especially of deep lesions in teeth with complex anatomical features – is impossible to 
achieve [2]. Therefore, a complete non-surgical resolution of deeper pockets is unrealistic in 
most cases and persisting problems are based on an ongoing residual bacterial challenge [3].  
To improve the efficacy of non-surgical periodontal therapy, several options are available to 
additionally remove the bacterial remnants mainly by chemical (antiseptics and antibiotics) or 
physical (lasers or air-polishing) means [4-6]. The latter, unfortunately, still have the 
disadvantage of relying on the adequate access with the tip to reach the affected sites, which 
may hamper or reduce its efficacy similar to conventional scaling devices [7, 8]. Whereas the 
use of systemically administered antibiotics is very effective, the risk of resistance formation 
and systemic side-effects may limit their routine use [9, 10]. Therefore, locally applied 
antiseptics are a valuable alternative [11]. They are cheap, easy to use by irrigation syringe 
application, have less side-effects and produce no bacterial resistance [12]. However, a 
universally applicable and highly effective formulation has not been identified so far and 
products are not available on the market apart from gels and solutions. As an antibacterial 
agent, chlorhexidine has been widely used, but the clinical efficiency is questionable as an 
adjunct to scaling and root planning in the available formulations [13].  
PVP-iodine could be a candidate as it represents an antiseptic with a broad antibacterial 
spectrum covering Gram-positive and -negative bacteria and mycobacteria, [14] 
Staphylococcus spp., Candida albicans [15] and periopathogenic germs. [16, 17]. A 
systematic review focusing on PVP-iodine as an adjunct to scaling and root planning proved 
evidence for an improved therpeutical effect regarding pocket depth reduction [18]. The 
clinical benefit however is still smaller as compared to systemic antibiotics or surgical 
interventions. Due to gingival crevicular fluid flow and bleeding from the pockets, the 
concentration of the active agent applied in the form of solutions and its time of action is too 
small in most studies. Thus, there is still a need to search for a higher substantivity of drugs 
that aim to disinfect periodontal pockets with adequate antibacterial performance at least 
during the treatment time. One approach is to apply ointments. Only one study evaluated the 
clearance of PVP-iodine delivered as solution or ointment in periodontal pockets and showed 
indeed that the application of PVP-iodine ointment in periodontal pockets allows a prolonged 
remnant effect as compared to the use of a solution when applied to sites without previous 
instrumentation. The mean concentrations of the gel and solution were small, accounting for 
6.14 µg/ml and 4.44 µg/ml (1 min; ≤ 0.028), 3.20 µg/ml and 1.44 µg/ml (5 min; ≥ 0.126), 
0.69 µg/ml and 0.23 µg/ml (15 min; p ≤ 0.019), respectively. Not surprisingly, in the pockets 
with previous debridement, the mean concentration even decreased significantly due to 
bleeding from the pocket [19]. Therefore, the ointment may offer some advantages over a 
solution, but improved pharmaceutical forms should be envisaged.  
Therefore, this study assessed in a first part the release of iodine resulting from mixtures of 
either a PVP-iodone solution or PVP-iodine powder incorporated into a commercially 
available wound paste of different compositions. Our hypothesis was that this approach would 
result in a prolonged iodine release of at least two hours with adequate antibacterial 
concentrations during treatment time. In the second part of the study the antibacterial effect of 
different concentrations of PVP-iodine were screened using an agar diffusion method 
assessing two representative periopathogenic bacteria.  
 
 
2 Methods 
2.1  Iodine Release  
Pure compounds and mixures of a commercially available wound paste (Solcoseryl® Dental-
Adhäsivpaste; Meda Pharma, Brütisellen, Switzerland) with PVP-iodine solution (Betadine, 
Mundipharma, Basel, Switzerland) and/or a PVP-iodine powder (30/06, BASF Burgbernheim, 
Germany) were prepared according to Table 1.  
 
Table 1: Iodine content in the respective formulations and mixtures. 
 
 
 
Compounds 
  Iodine content 
mg per   
g material  
% of the 
material 
Wound paste (WP) 0 0 
PVP-iodine powder (P) 108.4 10.8 
PVP-iodine solution (S) 7.8 0.8 
Mixtures   
WP:P:S = 1:1:0 56.5 5.7 
WP:P:S = 1:0:1 3.9 0.4 
WP:P:S = 1:1:1 40.2 4.0 
WP:P:S = 1:1:2 32.1 3.2 
WP:P:S = 1:2:1 58.4 5.8 
 
 
The compounds were weighed on a high precision scale and thoroughly mixed on a sterile 
glass plate subsequently. One gram of the resulting product was then taken and transferred to 
a custom-made mesh made of stainless steel (0.1 mm, inner width 1 mm, Figure 1).  
 
 
 
 
Figure 1: Illustration of the custom-made mesh made of stainless steel, which served for material transfer and 
stable immersion. 
 
This procedure allowed for a paste stabilization, quick removal and transport between the 
different vials during the immersion process while providing adequate contact of the material 
to the liquid. The paste mixtures were immersed for 5, 10, 15, 30, 60, 120, 180 and 240 
minutes at 37°C under constant motion in 10 mL simulated body fluid (SBF), which was 
prepared by dissolving reagent chemicals of NaCl, NaHCO3, KCl, K2HPO4x3H2O, 
MgCl2x6H2O, CaCl2 and Na2SO4 in ion-exchanged water. The ion concentrations of SBF in 
mM was: Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Ca- 147.8, HCO3-4.2, HPO42- 1.0, SO42- 0.5, 
respectively. The solution was buffered at physiological pH 7.4 (37°C) with 
tris(hydroxymethylaminomethane) and hydrochloric acid. After each time period, the liquid 
was collected and the test paste was transferred together with the mesh into a new vial. All 
materials were prepared, stored and measured in triplicates.  
The iodine determination of each sample was done in two aliquot extracts. The solutions were 
titrated according to a compendial method (Povidone iodine, Ph.Eur., 7th Edition, 2012), 
which involved titration of aqueous solution against a standardized sodium thiosulphate 
solution using starch as indicator. 
 
2.2  Agar Diffusion Test 
To study the antibacterial effects, aqueous solutions with concentrations coresponding to the 
PVP-iodine values determined in the first part of this study were prepared and tested on 
Porphyromonas gingivalis (OMZ 925) and Aggregatibacter actinomycetemcomitans (OMZ 
299). For the inoculum the two strains were grown separately in fluid universal medium 
(FUM) (9). Towards the end of the exponential growth phase the optical density of the cell 
suspensions was measured at a wavelength of 550 nm and adjusted by dilution with FUM to 
an optical density of 1.0. Columbia Blood Agar (CBA) without addition of blood (Becton 
Dickinson Microbiology Systems, Sparks, MD, USA) was prepared according to the 
manufacturer’s instructions. The agar was kept in a waterbath at 50°C until further use. For 
each strain Petri dishes were prepared by mixing 20 ml of agar with 1 ml of the corresponding 
inoculum. After solidifaction of the culture medium wells measuring 5 mm in diameter were 
punched out. These cavities were then filled with solutions of different PVP-iodine 
concentrations. These concentrations correlated with those obtained from the release trial of 
the first part of the study. The iodine solutions were composed by mixing PVP powder with 
SBF.  
Chlorhexidine (0.2%) and SBF alone were used as control media. After 48 h of anaerobic 
incubation at 37 °C, the zones of inhibition were measured using a caliper. The experiments 
were performed in triplicates.  
 
23  pH Measurement 
In addition, the pH of the solutions was measured in triplicates using a pH electrode 
(Metrohm, Zofingen, Switzerland) up to 4 hours until the pH was stable or the paste or 
material had been completely dissolved. In accordance, materials were immersed in either 
water of SBF at 37 °C. 
 
2.4  Data Presentation and Statistical Analyses 
Mean values and standard deviations of the iodine release in mg and expressed as percentage 
of the tested compound were calculated and presented in a table over time. At each time point, 
results of were compared using ANOVA and individual post hoc comparisons were 
performed using a Student’s t-test followed by Bonferroni correction for multiple 
comparisons. Significance was set at 95% (p ≤ 0.05). 
Diameters of zones of inhibition were presented for each measurment individually in a bar 
chart and mean values of the pH measurements were reported by a simple descriptive table. 
 
3 Results 
Whereas the theoretical iodine content is presented in Table 1, the iodine measurements after 
immersion for up to 4 hours are depicted in Table 2.  
Table 2: Iodine content in the respective formulations and mixtures at different evaluation times. Statistical comparison was made between different mixtures and different 
superscript capitals represent values, which are statistically significantly different (P>0.05). Mixtures indicated with the same superscript capitals represent iodine content values, 
which are not statistically significant different at a specific time point (read vertically; ANOVA, Bonferroni/Dunn correction). 
  5' 10' 15' 30' 60' 120' 240' 
Wound paste (WS) mg 
% 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
PVP-iodine powder (P) mg 
% 
97.9 ± 0.3 
90.3 ± 0.3 
1.1 ± 1.9 
1.0 ± 1.7 
1.8 ± 1.6 
1.6 ± 1.4 
1.2 ± 1.1 
1.1 ± 1.0 
0.7 ± 1.1 
0.6 ± 1.0 
  
PVP-iodine solution (S) mg 
% 
7.7 ± 0.2 
99.6 ± 0.6 
      
 
Mixtures 
        
WP:P:S = 1:1:0 mg 
% 
6.1 ± 2.9  A 
11.3 ± 5.4 
3.6 ± 2.3 A C 
6.8 ± 4.1 
3.4 ± 1.8   A 
6.1 ± 3.4 
5.0 ± 1.6   A 
9.2 ± 3.0 
7.4 ± 1.1    A 
13.5 ± 1.2 
10.7 ± 1.7   A 
19.7 ± 3.0 
12.0 ± 0.9 A 
17.2 ± 9.1 
WP:P:S = 1:0:1 mg 
% 
0 ± 0              B 
0 ± 0 
0 ± 0        B 
0 ± 0 
0 ± 0           B 
0 ± 0 
0 ± 0              B 
0 ± 0 
0 ± 0               B 
0 ± 0 
0 ± 0                 B 
0 ± 0 
0 ± 0          B 
0 ± 0 
WP:P:S = 1:1:1 mg 
% 
1.3 ± 0.4     BC 
3.3 ± 0.9 
1.6 ± 0.3  BC 
4.1 ± 0.9 
1.5 ± 0.2    C 
4.1 ± 0.6 
4.5 ± 1.8   A 
9.7 ± 1.0 
5.8 ± 1.9    AC 
14.4 ± 3.8 
10.3 ± 1.0  A 
25.0 ± 1.9 
11.4 ± 1.1 A 
26.1 ± 4.1 
WP:P:S = 1:1:2 mg 
% 
1.4 ± 0.4     BC 
4.5 ± 1.2 
1.4 ± 0.3  B 
4.6 ± 0.9 
1.4 ± 0.1  BC 
4.5 ± 0.2 
3.3 ± 0.3  A 
10.7 ± 0.9 
5.2 ± 0.4      C 
16.8 ± 1.2 
7.1± 0.6          C 
22.9 ± 15.9 
6.2 ± 0.5       C 
15.9 ± 8.1 
WP:P:S = 1:2:1 mg 
% 
3.4 ± 0.4       C 
6.0 ± 0.8 
3.6 ± 0.5 A 
6.4 ± 1.0 
3.4 ± 0.3  A 
6.0 ± 0.6 
8.9 ± 0.9     C 
15.9 ± 1.6 
13.5 ± 0.7      D   
24.0 ± 1.3 
15.2 ± 0.6      D 
27.0 ± 1.1 
3.5 ± 2.1         D 
4.9 ± 2.6 
As expected, the wound paste contained no iodine in its original formulation, whereas the 
original PVP-iodine released almost its complete iodine content in the first minutes. 
Interestingly, a mixture of the wound paste with the PVP-iodine solution alone showed no 
iodine release. Only combinations with the powder were able to release iodine for a prolonged 
time period. Cumulatively, 35-60% PVP-iodine was released from the pastes in the first hour. 
Overall, the powder/solution ratio influenced the iodine release. The highest iodine 
concentration in solution was detected for the mixture, in which more powder than solution 
had been added. 
The solubility of the paste was greatly influenced by the buffer capyity of the immersion 
media, which was clearly shown in the pH measurements. Materials subjected to water 
immersion resulted in acidic dissolution patterns (Table 3). 
 
Table 3: Measurements of pH of the original components and mixtures after immersion in water for up to 4 
hours (green: neutral pH-range; blue: basic pH-range, yellow-red-purple: acidic pH range; grey: not measurable, 
material dissolved) 
 0‘ 5' 10' 15' 30' 60' 120' 240' 
Wound paste (WP) 9.1 7.6 6.7 6.0 5.4 5.1 5.0 4.8 
PVP-iodine powder (P)  2.1 2.0 2.0 1.9    
PVP-iodine solution (S) 5.8        
WP:P:S = 1:1:0 7.0 3.7 3.7 3.6 3.3    
WP:P:S = 1:0:1 9.4 6.2 5.4 5.2 5.0 4.8   
WP:P:S = 1:1:1 6.7 4.4 4.4 4.5 4.2    
WP:P:S = 1:1:2 8.3 4.4 4.3 3.8 3.6 3.6   
WP:P:S = 1:2:1 7.1 3.3 3.2 3.2 3.2 3.2   
 
 
All mixtures with iodine powder resulted in pH values close to or below 4.5 within the first 
five minutes, which can be explained by the very acidic dissolution of the powder in water 
alone.  Only the mixture without powder addition exhibited a comparable pH decrease like the 
wound paste. All mixed compositions were completely dissolved in water after 60 minutes. In 
contrast, immersion in SBF showed a pH neutral dissolution of the wound paste and a less 
acidic behavior of the pure iodine compounds (Table 4).  
 
Table 4: Measurements of pH of the original components and mixtures after immersion in SBF for up to 4  
hours (green: neutral pH-range; blue: basic pH-range, yellow-red-purple: acidic pH range; grey: not  
measurable, material dissolved). 
 0‘ 5' 10' 15' 30' 60' 120' 240' 
Wound paste (WP) 7.3 7.3 7.3 7.3 7.3 7.3 7.2 6.9 
PVP-iodine powder (P)  6.7 7.0 7.0 7.0 5.9   
PVP-iodine solution (S) 7.3        
WP:P:S = 1:1:0 6.2 5.5 5.8 3.6 5.4 5.1 4.7 4.4 
WP:P:S = 1:0:1 7.2 7.4 7.4 7.3 7.3 7.3 7.3 7.3 
WP:P:S = 1:1:1 7.5 7.5 7.4 7.4 7.3 7.2 7.2 7.1 
WP:P:S = 1:1:2 6.4 6.6 6.4 6.4 6.2 6.0 5.7 5.2 
WP:P:S = 1:2:1 7.4 7.4 7.3 7.2 7.1 6.9 6.7 6.3 
 
Only the mixture with the powder alone showed pH values below 5 after 2 hours. Paste 
mixtures were more resistant to a pH decrease and more stable. None of the pastes was 
completely dissolved after the whole observation period.  
The antibacterial activity of PVP-solutions is shown in Figures 2 and 3.  
 
 
 
 Figure 2: Antibacterial effect against P. gingivalis assessed by agar diffusion method depicted as three individual 
measurements as inhibition zones in mm (SBF = simulated body fluid; CHX = chlorhexidine 0.2%; tested PVP-
iodine concentrations). 
 
 
Antibacterial effect against A. actinomycetemcomitans serotype b assessed by agar diffusion method depicted as 
three individual measurements as inhibition zones in mm (SBF = simulated body fluid; CHX = chlorhexidine 
0.2%; tested PVP-iodine concentrations). 
 
Clear zones of inhibition could be detected for A. actinomycetmcomitans and P. gingivalis for 
concentrations up to 6.25 and 3.125 mg, respectively. Below these concentrations, no 
inhibition zones were noted. A dose-dependent decrease in effectiveness was observed with 
decreasing concentrations.  
 
 
 
4 Discussion 
This study revealed a prolonged release of iodine if mixed with a commercially available 
wound paste for a time period of up to 4 hours. Hereby, iodine concentrations of more than 
1.0 mg/ml were found. Accordingly our hypothesis has been confirmed.  
In a recent clinical study, the clearance of PVP-iodine applied as a gel or solution was 
investigated in periodontal pockets [19]. The mean concentrations of the gel and solution, 
however, were much lower as compared to the results of the present study. Furthermore, 
concentrations decreased rapidly under clinical conditions within the first 15 minutes. They 
accounted for 6.1 µg/ml and 4.4 µg/ml after 1 min, 3.2 µg/ml and 1.4 µg/ml after 5 min and  
0.7 µg/ml and 0.2 µg/ml after 15 min, respectively. In the pockets with previous debridement 
the mean concentration was even lower after 1 minute (1.7 ± 2.0 µg/ml). Despite the 
conclusion that the application of PVP-iodine gel in periodontal pockets allowed for 
prolonged remnant effect as compared to that of the solution formula, other alternatives with 
slower release and higher iodine concentrations are still warranted. In the present study, we 
were able to create an iodine release with concentrations in the range of more than 1 mg/ml. 
However, concentrations lower than 6.25 mg/ml failed to be effective in killing the bacteria 
under the conditions of this investigation. However, studies of Higashitsutsumi et al. and 
Gocke et al. [15, 20] showed that PVP-iodine at very low concentrations is able to eliminate 
periodontal pathogens. Those studies, however, used a planktonic antibacterial assay in vitro. 
Schreier and co-workers  found that even lower PVP-iodine concentrations resulted in an 
efficacy maximum against Staphylococcus aureus, Candida albicans and Escherichia coli 
under laboratory conditions [14]. Yet, bacteria imbedded in the biofilm with its protective and 
adhesive extracellular matrix are much less susceptible to antiseptics [21, 22]. Nevertheless, 
PVP-iodine as a iodophor with a broad antibacterial spectrum, low potency for developing 
adverse reactions and low financial cost remains a valuable alternative that is free from the 
risk of developing bacterial resistance [23]. Furthermore, its utility has also been reported in 
non-surgical periodontal therapy [2, 23-25]. 
Since antiseptics, unlike antibiotics, are potentially toxic to both infectious and host cells, 
their application in humans is limited to infected wounds of skin and mucosa. Like other 
antiseptics, PVP-iodine has a nonselective mechanism of action, and the high concentrations 
used in the oral cavity may adversely affect the host cells. In vitro studies have already 
reported deleterious effects on fibroblasts and osteoblasts [26, 27]. The latter study has shown 
that 5 and 10% PVP-iodine caused cell death of host fibroblasts within minutes and that 
contact with 1% PVP-iodine resulted in a loss of the characteristic elongated cell shapeA 
previous study has assessed this aspect [28]. This study has shown that a short-time 
application of PVP-iodine in concentrations of 1:10 and higher lead to decreased viability and 
impaired differentiation. However, surviving cells showed good recovery and even a great 
mineralization potential. If this is the case with longer application at high doses has not been 
assessed yet and should be taken into consideration as well. The wound paste at least showed 
a good buffering capacity of the mixtures, which may reduce any tissue damage due to acidic 
conditions. 
 
5 Conclusions 
Within the limitations of this study, we conclude, that with a simple mixture of PVP-iodine 
powder together with a commercially available wound paste a prolonged release up to 4 hours 
of iodine can be achieved, which has an antibacterial effect. As a matter of course, the 
proposed mixture must yet prove both clinical innocuousness and efficacy before application 
in patients can be considered. 
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